The Drug Supply Chain Security Act (DSCSA) is scheduled to be fully enacted in November 2023, but many participants in the pharmaceutical supply chain are lobbying for a delay rolling out the initiative's much anticipated track-and-trace system. Other provisions of the law are still scheduled to kick in in November, however, including one that limits pharmacists' ability to see the full provenance—the "transaction log"—of medicines they receive from wholesalers.

On August 16, 2023, Partnership for Safe Medicines Executive Director Shabbir Safdar asked senior officials at the Food and Drug Administration to help pharmacists identify suspicious products by requiring wholesalers to provide them with the complete transaction log for every medicine they dispense until the track-and-trace system is fully online.